The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

Emergency overdose reversal kits have been installed at some public facilities in Durango. The kits contain naloxone, a nasal spray that can be used to help treat an opioid overdose. They also include ...

For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to ...

As major U.S. indexes like the Dow Jones, S&P 500, and Nasdaq Composite are on track for gains amid positive earnings reports and stable inflation data, investors continue to navigate a landscape ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...